Dublin, March 21, 2018 (GLOBE NEWSWIRE) -- The "Global Topical Drug Delivery Partnering 2012-2018: Deal trends, players, financials and forecasts" report has been added to ResearchAndMarkets.com's offering.

Topical Drug Delivery Partnering 2012-2018 report provides understanding and access to the topical drug delivery partnering deals and agreements entered into by the world's leading healthcare companies.

The report takes the reader through a comprehensive review Topical Drug Delivery deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Topical Drug Delivery partnering deals.

The report presents financial deal term values for Topical Drug Delivery deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Topical Drug Delivery partnering field; both the leading deal values and most active Topical Drug Delivery dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 200 online deal records of actual Topical Drug Delivery deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

A comprehensive series of appendices is provided organized by Topical Drug Delivery partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Topical Drug Delivery technologies and products.

Key benefits

Global Topical Drug Delivery Partnering 2012-2018: Deal trends, players, financials and forecasts provides the reader with the following key benefits:

• In-depth understanding of Topical Drug Delivery deal trends since 2012
• Access to headline, upfront, milestone and royalty data
• Analysis of the structure of Topical Drug Delivery agreements with numerous real life case studies
• Detailed access to actual Topical Drug Delivery contracts entered into by leading biopharma companies
• Identify most active Topical Drug Delivery dealmakers since 2012
• Insight into terms included in a Topical Drug Delivery partnering agreement, with real world examples
• Understand the key deal terms companies have agreed in previous deals
• Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

Topical Drug Delivery Partnering Terms and Agreements includes:

• Trends in Topical Drug Delivery dealmaking in the biopharma industry since 2012
• Analysis of Topical Drug Delivery deal structure
• Access to headline, upfront, milestone and royalty data
• Case studies of real-life Topical Drug Delivery deals
• Access to Topical Drug Delivery contract documents
• Leading Topical Drug Delivery deals by value since 2012
• Most active Topical Drug Delivery dealmakers since 2012

Available deals are listed by:

• Company A-Z
• Headline value
• Stage of development at signing
• Deal component type
• Specific therapy target
• Technology type
  

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Topical Drug Delivery dealmaking

2.1. Introduction
2.2. Topical Drug Delivery partnering over the years
2.3. Most active Topical Drug Delivery dealmakers
2.4. Topical Drug Delivery partnering by deal type
2.5. Topical Drug Delivery partnering by therapy area
2.6. Deal terms for Topical Drug Delivery partnering
2.6.1 Topical Drug Delivery partnering headline values
2.6.2 Topical Drug Delivery deal upfront payments
2.6.3 Topical Drug Delivery deal milestone payments
2.6.4 Topical Drug Delivery royalty rates

Chapter 3 - Leading Topical Drug Delivery deals

3.1. Introduction
3.2. Top Topical Drug Delivery deals by value

Chapter 4 - Most active Topical Drug Delivery dealmakers

4.1. Introduction
4.2. Most active Topical Drug Delivery dealmakers
4.3. Most active Topical Drug Delivery partnering company profiles

Chapter 5 - Topical Drug Delivery contracts dealmaking directory

5.1. Introduction
5.2. Topical Drug Delivery contracts dealmaking directory

Chapter 6 - Topical Drug Delivery dealmaking by technology type

Chapter 7 - Partnering resource center

7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

Appendices

Appendix 1 - Topical Drug Delivery deals by company A-Z
Appendix 2 - Topical Drug Delivery deals by stage of development
Appendix 3 - Topical Drug Delivery deals by deal type
Appendix 4 - Topical Drug Delivery deals by therapy area
Appendix 5 -Deal type definitions

For more information about this report visit https://www.researchandmarkets.com/research/gfs4q7/global_topical?w=12

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Drug Delivery